Economic Slowdown Puts Brakes On Simcere’s Profits
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Simcere Pharmaceutical Group posted lower-than-forecast earnings for 2008 due to the country's low rate of insurance coverage, combined with patients' cutting back on medical expenditures in the wake of the global recession, according to a senior executive
You may also be interested in...
Innovative Drug Developer Simcere Reports Falling Profits; Negotiates With Government Over Inclusion In National Insurance Catalogue
BEIJING - Simcere Pharmaceutical Group posted lower-than-expected earnings for the third quarter of 2009 as the worldwide economic slowdown and limited health insurance coverage inside China hurt sales of the outfit's most innovative and expensive biopharmaceutical, according to Simcere's leadership
Innovative Drug Developer Simcere Reports Falling Profits; Negotiates With Government Over Inclusion In National Insurance Catalogue
BEIJING - Simcere Pharmaceutical Group posted lower-than-expected earnings for the third quarter of 2009 as the worldwide economic slowdown and limited health insurance coverage inside China hurt sales of the outfit's most innovative and expensive biopharmaceutical, according to Simcere's leadership
China Set To Launch Sweeping Health System Reforms, Aimed In Part At Reversing Stratified Access To Medicine, Hospitals, Insurance
BEIJING - China's central government is set to launch sweeping reforms of the country's health system, with the ultimate goal of providing universal health care by the year 2020